3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride

C23H34ClN3O3 — CID 18943734

IUPAC3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride
SMILESCN1CCc2ccc(N3CCN(C4CCC(CCC(=O)O)CC4)C3=O)cc2CC1.Cl
InChIInChI=1S/C23H33N3O3.ClH/c1-24-12-10-18-5-8-21(16-19(18)11-13-24)26-15-14-25(23(26)29)20-6-2-17(3-7-20)4-9-22(27)28;/h5,8,16-17,20H,2-4,6-7,9-15H2,1H3,(H,27,28);1H
InChIKeyIQYVMGBDJCHSOH-UHFFFAOYSA-N
MW436.00 g/mol
LogP3.80
Rot. Bonds5

About 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride

3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride (PubChem CID 18943734) has the molecular formula C23H34ClN3O3 and a molecular weight of 436.00 g/mol. Its IUPAC name is 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride.

Molecular Properties

Compound Name3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride
PubChem CID18943734
Molecular FormulaC23H34ClN3O3
Molecular Weight436.00 g/mol
Exact Mass435.23
IUPAC Name3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride
SMILESCN1CCc2ccc(N3CCN(C4CCC(CCC(=O)O)CC4)C3=O)cc2CC1.Cl
InChIInChI=1S/C23H33N3O3.ClH/c1-24-12-10-18-5-8-21(16-19(18)11-13-24)26-15-14-25(23(26)29)20-6-2-17(3-7-20)4-9-22(27)28;/h5,8,16-17,20H,2-4,6-7,9-15H2,1H3,(H,27,28);1H
InChIKeyIQYVMGBDJCHSOH-UHFFFAOYSA-N
XLogP3.80
TPSA64.09 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500436.00
LogP ≤ 53.80
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride?
The IUPAC name of 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride (CID 18943734) is 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride.
What is the SMILES notation for 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride?
The canonical SMILES for 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride is CN1CCc2ccc(N3CCN(C4CCC(CCC(=O)O)CC4)C3=O)cc2CC1.Cl.
What is the InChIKey of 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride?
The InChIKey is IQYVMGBDJCHSOH-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H33N3O3.ClH/c1-24-12-10-18-5-8-21(16-19(18)11-13-24)26-15-14-25(23(26)29)20-6-2-17(3-7-20)4-9-22(27)28;/h5,8,16-17,20H,2-4,6-7,9-15H2,1H3,(H,27,28);1H.
What are the key properties of 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride?
3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride has a molecular weight of 436.00 g/mol, XLogP of 3.80, 5 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-[3-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)-2-oxoimidazolidin-1-yl]cyclohexyl]propanoic acid;hydrochloride is sourced from PubChem (CID 18943734), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).